Bispecific T Cell Engager Therapeutics Market Overview

Ajouter une nouvelle offre d'emploi Health

2026-07-06 12:06:32 -

The Bispecific T Cell Engager Therapeutics Market was valued at $7.0 billion in 2024 and is projected to reach $21.0 billion by 2035, growing at a CAGR of 10.6%. These innovative therapies bridge T-cells and tumor cells simultaneously, redirecting the immune system to destroy cancer cells without requiring genetic modification of patient cells. The market encompasses bispecific monoclonal...

0 Commentaires 0 Parts 51 Vue 0 Aperçu